Literature DB >> 11450684

Oral manifestations related to immunosuppression degree in HIV-positive children.

L C Santos1, G F Castro, I P de Souza, R H Oliveira.   

Abstract

Oral manifestations often found in HIV-infected children are frequently the first clinical sign of the infection. This article aims to report the prevalence of oral manifestations in soft tissues and their relationship with the degree of immunosuppression in 80 HIV-infected patients (average age 6.30 +/- 3.32 years old) at the IPPMG-UFRJ. Thirty children (38%) presented some type of oral lesion and the percentage of CD4 was lower than that found in lesion-free children (p < 0.05); 22.5% presented candidiasis, 17.5% gingivitis, 8.8% enlargement of parotids, 1.3% herpes simplex and 1.3% hairy leukoplakia. Of the 30 children with lesions, 70% showed severe immunosuppression, 23.3% moderate immunosuppression and in only 6.7% was immunosuppression absent. Oral manifestations were directly related to the degree of immunosuppression and such lesions can be considered as indicators of the progression of the HIV infection in children.

Entities:  

Mesh:

Year:  2001        PMID: 11450684

Source DB:  PubMed          Journal:  Braz Dent J        ISSN: 0103-6440


  12 in total

Review 1.  Current trends and new developments in HIV research and periodontal diseases.

Authors:  Mark I Ryder; Caroline Shiboski; Tzy-Jyun Yao; Anna-Barbara Moscicki
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

2.  Prevalence of periodontal diseases in a multicenter cohort of perinatally HIV-infected and HIV-exposed and uninfected youth.

Authors:  Mark I Ryder; Tzy-Jyun Yao; Jonathan S Russell; Anna-Barbara Moscicki; Caroline H Shiboski
Journal:  J Clin Periodontol       Date:  2016-11-22       Impact factor: 8.728

3.  Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.

Authors:  Luciana Pomarico; Daniella Ferraz Cerqueira; Rosangela Maria de Araujo Soares; Ivete Pomarico Ribeiro de Souza; Gloria Fernanda Barbosa de Araujo Castro; Sigmund Socransky; Anne Haffajee; Ricardo Palmier Teles
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-08

4.  Antifungal activity, biofilm-controlling effect, and biocompatibility of poly(N-vinyl-2-pyrrolidinone)-grafted denture materials.

Authors:  Xinbo Sun; Zhengbing Cao; Chih-Ko Yeh; Yuyu Sun
Journal:  Colloids Surf B Biointerfaces       Date:  2013-04-30       Impact factor: 5.268

5.  Oral manifestation of HIV/AIDS infections in paediatric Nigerian patients.

Authors:  Adetokunbo Rafel Adebola; Solomon Ibiyemi Adeleke; Maryam Mukhtar; Otasowie Daniel Osunde; Benjamin Idemudia Akhiwu; Akinola Ladeinde
Journal:  Niger Med J       Date:  2012-07

6.  Associated oral lesions in human immunodefeciency virus infected children of age 1 to 14 years in anti retroviral therapy centers in Tamil Nadu.

Authors:  R Krishna Kumar; G Mohan; N Venugopal Reddy; V Arun Prasad Rao; M Shameer; Ananthi Christopher
Journal:  Contemp Clin Dent       Date:  2013-10

Review 7.  Applications of the FIV Model to Study HIV Pathogenesis.

Authors:  Craig Miller; Zaid Abdo; Aaron Ericsson; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2018-04-20       Impact factor: 5.048

8.  Oral Manifestations Related To CD4 Lymphocyte Count in HIV-Positive Patients.

Authors:  Poorandokht Davoodi; Mina Hamian; Reza Nourbaksh; Fatemeh Ahmadi Motamayel
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2010-12-21

Review 9.  Diagnosis and treatment of HIV-associated manifestations in otolaryngology.

Authors:  Emily Iacovou; Petros V Vlastarakos; George Papacharalampous; George Kampessis; Thomas P Nikolopoulos
Journal:  Infect Dis Rep       Date:  2012-01-02

10.  Role of Candida species from HIV infected children in enamel caries lesions: an in vitro study.

Authors:  Senda Charone; Maristela Barbosa Portela; Karol de Oliveira Martins; Rosangela Maria Soares; Gloria Fernanda Castro
Journal:  J Appl Oral Sci       Date:  2017 Jan-Feb       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.